Senior Accountant

About Radionetics

Radionetics Oncology, a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications, is poised to capitalize on the increasing demand for novel radiotherapeutics. The company’s platform technology uses small molecule targeting to deliver therapeutic radioisotopes aimed at novel targets on a broad range of cancers by binding selectively to peptide receptors that are overexpressed on these tumors.

This small molecule technology addresses many of the significant challenges currently facing peptide and protein targeted radiotherapeutics. Spun out of Crinetics (Nasdaq: CRNX) in 2021 and financed by 5AM Ventures and Frazier Healthcare, Radionetics is advancing a pipeline of multiple lead drug candidates pursuing first‑in‑class targets to treat a broad range of cancers. According to commercially available market research reports, the market for radiopharmaceuticals is expected to rise to $12.6 billion by 2027.

The Senior Accountant will play a critical role in the day‑to‑day financial operations of Radionetics. This individual will be a key contributor in the month‑end close process, manage the accounts payable function, and assist with the technical execution of clinical trial accruals. The ideal candidate is a Big‑4‑trained CPA who is ready to transition into a hands‑on biotech environment, bringing a high level of technical rigor and "audit‑ready" documentation to a growing R&D organization.

This role reports to the Senior Manager of Accounting and will work closely with the Controller, CFO, and other cross‑functional teams.

• General Ledger & Close: Assist with the month‑end, quarterly, and year‑end close procedures. Prepare journal entries and account reconciliations related to cash, prepaids, fixed assets, and general accruals and assist with the R&D accounting and clinical trial accruals process. Prepare monthly financial statements and flux analyses.
• Purchasing: Oversee the end‑to‑end purchasing workflow to ensure proper coding, internal approvals/compliance with controls, and vendor management. Serve as day‑to‑day accounting resource for internal stakeholders for all purchasing and contracting inquiries.
• AP Oversight: Review and manage all aspects of the accounts payable process.
• Internal Controls: Maintain and strengthen internal controls over financial reporting and ensure all processes are "IPO‑ready."
• Payroll: Process semi‑monthly payroll, including collection of relevant support documentation and approvals. Support headcount, payroll, and benefits‑related accounting entries/reconciliations.
• Audit Support: Serve as a point of contact for external auditors, preparing work papers and providing technical explanations for accounting treatments.
• Clinical Trial Accounting: Assist in the month‑end clinical accrual process. Collaborate cross‑functionally with Clinical Operations and CROs to track patient enrollment, site activities, and milestone payments to ensure accurate expense recognition.
• Special Projects: Support the Controller/CFO with ad‑hoc technical accounting research, tax filings, and preparation of materials for board meetings.

• Education: BA/BS in Accounting; CPA license is required.
• Experience: 2–4 years of progressive accounting experience. Public accounting experience is required.
• Industry Knowledge: Previous experience in the Life Sciences/Biotech sector is preferred, specifically regarding clinical trial accruals and R&D accounting.
• Technical
  
  Skills:
  
  Strong understanding of U.S. GAAP and SOX compliance.
• Systems: Proficiency in Excel (advanced formulas, pivot tables), experience with Quickbooks, Prendio, , Expensify is preferred.
• Communication: Ability to translate complex accounting concepts for non‑finance stakeholders (e.g., Project Managers and Scientists).
• Mindset: A "roll‑up‑your‑sleeves" attitude with the ability to thrive in a fast‑paced, high‑growth startup environment.

The position is based in San Diego, CA. Some duties may be performed on a hybrid schedule.

Radionetics…